Mpox is a rare, but potentially serious, viral illness that typically involves flu-like symptoms, swollen lymph nodes and a rash that includes bumps that are filled with fluid before scabbing ...

A recent study carried out at Charité Universitätsmedizin Berlin and published in The Lancet Infectious Diseases has shown that one dose of Bavarian Nordic’s Jynneos (smallpox and mpox vaccine ...

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS ...

Mpox can be lethal, especially for children under five years old. The mortality rate for clade I is between 3% and 10%. The ...

At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted on recommendations for several ...

The freeze-dried formulation provides flexibility with regard to storage and shelf life. The Food and Drug Administration (FDA) has approved a new freeze-dried formulation of Jynneos ® (smallpox ...

The company said the newly approved formulation of its vaccine, Jynneos, provides advantages in terms of transportation, storage conditions and shelf life, which are important factors for long ...

There are currently two vaccines including JYNNEOS and ACAM2000 approved by the US Food and Drug Administration (US FDA) for the prevention of mpox and smallpox diseases in adults of 18 years of ...